DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02005757 (ClinicalTrials.gov)	November 2013	4/12/2013	Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED)	Open Label, Multicenter, Randomized Study to Assess the Efficacy and Safety of Mizoribine in Active Rheumatoid Arthritis Patients Unsuccessfully Treated With Disease-modifying Antirheumatic Drug	Rheumatoid Arthritis	Drug: Bredinin tablet 150mg;Drug: Bredinin tablet 50mg	Chong Kun Dang Pharmaceutical	NULL	Recruiting	20 Years	80 Years	Both	60	Phase 2	Korea, Republic of

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02005757
(ClinicalTrials.gov)

November 2013

4/12/2013

Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED)

Open Label, Multicenter, Randomized Study to Assess the Efficacy and Safety of Mizoribine in Active Rheumatoid Arthritis Patients Unsuccessfully Treated With Disease-modifying Antirheumatic Drug

Rheumatoid Arthritis

Drug: Bredinin tablet 150mg;Drug: Bredinin tablet 50mg

Chong Kun Dang Pharmaceutical

NULL

Recruiting

20 Years

80 Years

Both

Phase 2

Korea, Republic of